Search

Sara Elizabeth Townsley

Examiner (ID: 5080, Phone: (571)270-7672 , Office: P/1629 )

Most Active Art Unit
1629
Art Unit(s)
1629, 1612, 1613
Total Applications
512
Issued Applications
97
Pending Applications
84
Abandoned Applications
350

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10499544 [patent_doc_number] => 09227937 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning' [patent_app_type] => utility [patent_app_number] => 13/261513 [patent_app_country] => US [patent_app_date] => 2011-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7519 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261513 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/261513
Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning May 11, 2011 Issued
Array ( [id] => 8892263 [patent_doc_number] => 20130165446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/696978 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 116710 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696978 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/696978
BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE May 10, 2011 Abandoned
Array ( [id] => 10032612 [patent_doc_number] => 09073918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5' [patent_app_type] => utility [patent_app_number] => 13/697421 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61085 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697421 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/697421
Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5 May 9, 2011 Issued
Array ( [id] => 8685127 [patent_doc_number] => 20130053411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION' [patent_app_type] => utility [patent_app_number] => 13/695628 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10053 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695628 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/695628
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION Apr 28, 2011 Abandoned
Array ( [id] => 8633382 [patent_doc_number] => 20130025185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'CRAWLING INSECT BARRIER' [patent_app_type] => utility [patent_app_number] => 13/640508 [patent_app_country] => US [patent_app_date] => 2011-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 2594 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640508 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/640508
CRAWLING INSECT BARRIER Apr 11, 2011 Abandoned
Array ( [id] => 6166334 [patent_doc_number] => 20110173928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'PROCESS TO IMPROVE STABILITY OF A PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/074183 [patent_app_country] => US [patent_app_date] => 2011-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2461 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20110173928.pdf [firstpage_image] =>[orig_patent_app_number] => 13074183 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/074183
PROCESS TO IMPROVE STABILITY OF A PHARMACEUTICAL COMPOSITION Mar 28, 2011 Abandoned
Array ( [id] => 8792745 [patent_doc_number] => 20130109714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'NEURODEGENERATIVE DISEASE THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 13/637538 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7626 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637538 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/637538
NEURODEGENERATIVE DISEASE THERAPEUTIC AGENT Mar 24, 2011 Abandoned
Array ( [id] => 8416718 [patent_doc_number] => 20120244218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Calcium supplement' [patent_app_type] => utility [patent_app_number] => 13/065643 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4693 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13065643 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/065643
Calcium supplement Mar 24, 2011 Abandoned
Array ( [id] => 10620542 [patent_doc_number] => 09339466 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-17 [patent_title] => 'Polymorphic forms of ST-246 and methods of preparation' [patent_app_type] => utility [patent_app_number] => 13/069813 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18720 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13069813 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/069813
Polymorphic forms of ST-246 and methods of preparation Mar 22, 2011 Issued
Array ( [id] => 7697053 [patent_doc_number] => 20110229537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'ORAL SUPPLEMENT' [patent_app_type] => utility [patent_app_number] => 13/050523 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4200 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229537.pdf [firstpage_image] =>[orig_patent_app_number] => 13050523 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/050523
ORAL SUPPLEMENT Mar 16, 2011 Abandoned
Array ( [id] => 6102207 [patent_doc_number] => 20110165700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'CLASSES OF COMPOUNDS THAT INTERACT WITH INTEGRINS' [patent_app_type] => utility [patent_app_number] => 13/047601 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5882 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165700.pdf [firstpage_image] =>[orig_patent_app_number] => 13047601 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/047601
CLASSES OF COMPOUNDS THAT INTERACT WITH INTEGRINS Mar 13, 2011 Abandoned
Array ( [id] => 5972595 [patent_doc_number] => 20110152228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE' [patent_app_type] => utility [patent_app_number] => 13/038483 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4925 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152228.pdf [firstpage_image] =>[orig_patent_app_number] => 13038483 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/038483
SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE Mar 1, 2011 Abandoned
Array ( [id] => 8842007 [patent_doc_number] => 20130137635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/577755 [patent_app_country] => US [patent_app_date] => 2011-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52462 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577755 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/577755
TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE Feb 8, 2011 Abandoned
Array ( [id] => 7657316 [patent_doc_number] => 20110306585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Metal Complexes of N-Heterocyclic Carbenes' [patent_app_type] => utility [patent_app_number] => 13/021337 [patent_app_country] => US [patent_app_date] => 2011-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16664 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306585.pdf [firstpage_image] =>[orig_patent_app_number] => 13021337 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/021337
Metal complexes of N-heterocyclic carbenes Feb 3, 2011 Issued
Array ( [id] => 6055956 [patent_doc_number] => 20110112316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TIGECYCLINE CRYSTALLINE FORMS AND PROCESSES FOR PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 13/006719 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4508 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112316.pdf [firstpage_image] =>[orig_patent_app_number] => 13006719 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/006719
Tigecycline crystalline forms and processes for preparation thereof Jan 13, 2011 Issued
Array ( [id] => 6121596 [patent_doc_number] => 20110077292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'FORSKOLIN CARBONATES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/973860 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4913 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077292.pdf [firstpage_image] =>[orig_patent_app_number] => 12973860 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/973860
FORSKOLIN CARBONATES AND USES THEREOF Dec 19, 2010 Abandoned
Array ( [id] => 6213908 [patent_doc_number] => 20110136750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/957555 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19273 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136750.pdf [firstpage_image] =>[orig_patent_app_number] => 12957555 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/957555
COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS Nov 30, 2010 Abandoned
Array ( [id] => 6213907 [patent_doc_number] => 20110136749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/957551 [patent_app_country] => US [patent_app_date] => 2010-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19227 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136749.pdf [firstpage_image] =>[orig_patent_app_number] => 12957551 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/957551
COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS Nov 30, 2010 Abandoned
Array ( [id] => 6033326 [patent_doc_number] => 20110082154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'Sigma ligands for neuronal regeneration and functional recovery' [patent_app_type] => utility [patent_app_number] => 12/926594 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12488 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082154.pdf [firstpage_image] =>[orig_patent_app_number] => 12926594 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/926594
Sigma ligands for neuronal regeneration and functional recovery Nov 28, 2010 Abandoned
Array ( [id] => 10560634 [patent_doc_number] => 09284292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'Sialochimeric compounds' [patent_app_type] => utility [patent_app_number] => 13/512306 [patent_app_country] => US [patent_app_date] => 2010-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16369 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512306 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/512306
Sialochimeric compounds Nov 24, 2010 Issued
Menu